The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Infant, Very Low Birth Weight

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Infant, Very Low Birth Weight


Psychiatry related information on Infant, Very Low Birth Weight

  • The authors investigated the validity of the Clinical Adaptive Test (CAT)/Clinical Linguistic and Auditory Milestone Scale (CLAMS) for developmental screening and early prediction in very low birth weight (VLBW) infants, using the Bayley Scales of Infant Development II (BSID-II) as a reference standard [6].

High impact information on Infant, Very Low Birth Weight


Chemical compound and disease context of Infant, Very Low Birth Weight


Biological context of Infant, Very Low Birth Weight


Anatomical context of Infant, Very Low Birth Weight


Associations of Infant, Very Low Birth Weight with chemical compounds


Gene context of Infant, Very Low Birth Weight


Analytical, diagnostic and therapeutic context of Infant, Very Low Birth Weight


  1. Prenatal magnesium sulfate exposure and the risk for cerebral palsy or mental retardation among very low-birth-weight children aged 3 to 5 years. Schendel, D.E., Berg, C.J., Yeargin-Allsopp, M., Boyle, C.A., Decoufle, P. JAMA (1996) [Pubmed]
  2. Pituitary-adrenal suppression and recovery in preterm very low birth weight infants after dexamethasone treatment for bronchopulmonary dysplasia. Ng, P.C., Wong, G.W., Lam, C.W., Lee, C.H., Fok, T.F., Wong, M.Y., Wong, W., Chan, D.C. J. Clin. Endocrinol. Metab. (1997) [Pubmed]
  3. Effects of prophylactic low-dose indomethacin on hemodynamics in very low birth weight infants. Yanowitz, T.D., Yao, A.C., Werner, J.C., Pettigrew, K.D., Oh, W., Stonestreet, B.S. J. Pediatr. (1998) [Pubmed]
  4. Candidal sepsis and meningitis in a very-low-birth-weight infant successfully treated with fluconazole and flucytosine. Marr, B., Gross, S., Cunningham, C., Weiner, L. Clin. Infect. Dis. (1994) [Pubmed]
  5. Effects of early dexamethasone therapy on pulmonary mechanics and chronic lung disease in very low birth weight infants: a randomized, controlled trial. Durand, M., Sardesai, S., McEvoy, C. Pediatrics (1995) [Pubmed]
  6. Validity of the Clinical Adaptive Test (CAT)/Clinical Linguistic and Auditory Milestone Scale (CLAMS) as a screening instrument for very low birth weight infants in Taiwan. Wang, L.W., Wang, S.T., Huang, C.C. Journal of developmental and behavioral pediatrics : JDBP. (2005) [Pubmed]
  7. A multicenter trial of two dexamethasone regimens in ventilator-dependent premature infants. Papile, L.A., Tyson, J.E., Stoll, B.J., Wright, L.L., Donovan, E.F., Bauer, C.R., Krause-Steinrauf, H., Verter, J., Korones, S.B., Lemons, J.A., Fanaroff, A.A., Stevenson, D.K. N. Engl. J. Med. (1998) [Pubmed]
  8. Recombinant erythropoietin in very-low-birth-weight infants. Carnielli, V.P., Da Riol, R., Montini, G. N. Engl. J. Med. (1994) [Pubmed]
  9. G protein in very low birth-weight infants. Vásárhelyi, B., Kocsis, I., Schuler, A., Nobilis, A., Tulassay, T. Lancet (2000) [Pubmed]
  10. Phenobarbitone for prevention of periventricular haemorrhage in very low birth-weight infants. A randomised double-blind trial. Whitelaw, A., Placzek, M., Dubowitz, L., Lary, S., Levene, M. Lancet (1983) [Pubmed]
  11. Ethamsylate reduces the incidence of periventricular haemorrhage in very low birth-weight babies. Morgan, M.E., Benson, J.W., Cooke, R.W. Lancet (1981) [Pubmed]
  12. Low plasma retinol concentrations increase the risk of developing bronchopulmonary dysplasia and long-term respiratory disability in very-low-birth-weight infants. Spears, K., Cheney, C., Zerzan, J. Am. J. Clin. Nutr. (2004) [Pubmed]
  13. Cognitive outcome at 4 1/2 years of very low birth weight infants enrolled in the multicenter indomethacin intraventricular hemorrhage prevention trial. Ment, L.R., Westerveld, M., Makuch, R., Vohr, B., Allan, W.C. Pediatrics (1998) [Pubmed]
  14. Trial of vitamin A supplementation in very low birth weight infants at risk for bronchopulmonary dysplasia. Pearson, E., Bose, C., Snidow, T., Ransom, L., Young, T., Bose, G., Stiles, A. J. Pediatr. (1992) [Pubmed]
  15. Glucose production and gluconeogenesis are negatively related to body weight in mechanically ventilated, very low birth weight neonates. Keshen, T., Miller, R., Jahoor, F., Jaksic, T., Reeds, P.J. Pediatr. Res. (1997) [Pubmed]
  16. Does phenobarbitone prevent periventricular hemorrhage in very low-birth-weight babies?: a controlled trial. Morgan, M.E., Massey, R.F., Cooke, R.W. Pediatrics (1982) [Pubmed]
  17. Gluconeogenesis in very low birth weight infants receiving total parenteral nutrition. Sunehag, A.L., Haymond, M.W., Schanler, R.J., Reeds, P.J., Bier, D.M. Diabetes (1999) [Pubmed]
  18. Potential risk factors for vertical HIV-1 transmission in Catalonia, Spain: the protective role of cesarean section. The Working Group on HIV-1 Vertical Transmission in Catalonia. Maguire, A., Sánchez, E., Fortuny, C., Casabona, J. AIDS (1997) [Pubmed]
  19. Pharmacokinetics of fluconazole in very low birth weight infants during the first two weeks of life. Saxén, H., Hoppu, K., Pohjavuori, M. Clin. Pharmacol. Ther. (1993) [Pubmed]
  20. The pituitary-adrenal responses to exogenous human corticotropin-releasing hormone in preterm, very low birth weight infants. Ng, P.C., Wong, G.W., Lam, C.W., Lee, C.H., Wong, M.Y., Fok, T.F., Wong, W., Chan, D.C. J. Clin. Endocrinol. Metab. (1997) [Pubmed]
  21. Results of controlled double-blind study of thyroid replacement in very low-birth-weight premature infants with hypothyroxinemia. Chowdhry, P., Scanlon, J.W., Auerbach, R., Abbassi, V. Pediatrics (1984) [Pubmed]
  22. Effects of parenteral L-carnitine supplementation on fat metabolism and nutrition in premature neonates. Bonner, C.M., DeBrie, K.L., Hug, G., Landrigan, E., Taylor, B.J. J. Pediatr. (1995) [Pubmed]
  23. Feeding the premature infant in the 20th century. Greer, F.R. J. Nutr. (2001) [Pubmed]
  24. Angiotensin II type 1 receptor A1166C polymorphism and prophylactic indomethacin treatment induced ductus arteriosus closure in very low birth weight neonates. Treszl, A., Szabo, M., Dunai, G., Nobilis, A., Kocsis, I., Machay, T., Tulassay, T., Vasarhelyi, B. Pediatr. Res. (2003) [Pubmed]
  25. Thyroid function in very low birth weight infants. Klein, R.Z., Carlton, E.L., Faix, J.D., Frank, J.E., Hermos, R.J., Mullaney, D., Nelson, J.C., Rojas, D.A., Mitchell, M.L. Clin. Endocrinol. (Oxf) (1997) [Pubmed]
  26. The effect of dexamethasone on time averaged mean velocity in the middle cerebral artery in very low birth weight infants. Ohlsson, A., Bottu, J., Govan, J., Ryan, M.L., Myhr, T., Fong, K. Eur. J. Pediatr. (1994) [Pubmed]
  27. Effect of different vitamin A intakes on very-low-birth-weight infants. Koo, W.W., Krug-Wispe, S., Succop, P., Tsang, R.C., Neylan, M. Am. J. Clin. Nutr. (1995) [Pubmed]
  28. Vitamin E supplementation in very-low-birth-weight infants: long-term follow-up at two different levels of vitamin E supplementation. Rönnholm, K.A., Dostálová, L., Siimes, M.A. Am. J. Clin. Nutr. (1989) [Pubmed]
  29. Glutamine-enriched enteral nutrition in very-low-birth-weight infants and effects on feeding tolerance and infectious morbidity: a randomized controlled trial. van den Berg, A., van Elburg, R.M., Westerbeek, E.A., Twisk, J.W., Fetter, W.P. Am. J. Clin. Nutr. (2005) [Pubmed]
  30. Pituitary-adrenal suppression in preterm, very low birth weight infants after inhaled fluticasone propionate treatment. Ng, P.C., Fok, T.F., Wong, G.W., Lam, C.W., Lee, C.H., Wong, M.Y., Lam, K., Ma, K.C. J. Clin. Endocrinol. Metab. (1998) [Pubmed]
  31. Interleukin-4 and 13 concentrations in infants at risk to develop Bronchopulmonary Dysplasia. Baier, R.J., Loggins, J., Kruger, T.E. BMC pediatrics [electronic resource]. (2003) [Pubmed]
  32. Lower prevalence of IL-4 receptor alpha-chain gene G variant in very-low-birth-weight infants with necrotizing enterocolitis. Treszl, A., Héninger, E., Kálmán, A., Schuler, A., Tulassay, T., Vásárhelyi, B. J. Pediatr. Surg. (2003) [Pubmed]
  33. Monocyte chemoattractant protein-1 and interleukin-8 are increased in bronchopulmonary dysplasia: relation to isolation of Ureaplasma urealyticum. Baier, R.J., Loggins, J., Kruger, T.E. J. Investig. Med. (2001) [Pubmed]
  34. The association of the carrier state of the tumor necrosis factor-alpha (TNFalpha) -308A allele with the duration of oxygen supplementation in preterm neonates. Bokodi, G., Treszl, A., Derzbach, L., Balogh, A., Vásárhelyi, B. Eur. Cytokine Netw. (2005) [Pubmed]
  35. Effect of high-dose vitamin D supplementation on radiographically detectable bone disease of very low birth weight infants. Evans, J.R., Allen, A.C., Stinson, D.A., Hamilton, D.C., St John Brown, B., Vincer, M.J., Raad, M.A., Gundberg, C.M., Cole, D.E. J. Pediatr. (1989) [Pubmed]
  36. Randomized placebo-controlled trial of a 42-Day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants. Kothadia, J.M., O'Shea, T.M., Roberts, D., Auringer, S.T., Weaver, R.G., Dillard, R.G. Pediatrics (1999) [Pubmed]
  37. Risk of intracranial hemorrhage and other adverse outcomes after cocaine exposure in a cohort of 323 very low birth weight infants. Dusick, A.M., Covert, R.F., Schreiber, M.D., Yee, G.T., Browne, S.P., Moore, C.M., Tebbett, I.R. J. Pediatr. (1993) [Pubmed]
  38. Retrolental fibroplasia and vitamin E in the preterm infant--comparison of oral versus intramuscular:oral administration. Hittner, H.M., Speer, M.E., Rudolph, A.J., Blifeld, C., Chadda, P., Holbein, M.E., Godio, L.B., Kretzer, F.L. Pediatrics (1984) [Pubmed]
  39. Recurrence of symptomatic patent ductus arteriosus in extremely premature infants, treated with indomethacin. Mellander, M., Leheup, B., Lindstrom, D.P., Palme, C., Graham, T.P., Stahlman, M.T., Cotton, R.B. J. Pediatr. (1984) [Pubmed]
WikiGenes - Universities